Biological Evaluation of a Novel Anti-inflammatory Treatment in Immune-mediated Inflammatory Diseases

NCT02839278 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
150
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Centre Hospitalier Universitaire de Besancon